NHF is pleased to announce the 2009 Kevin Child Scholarship Winner: Nicholas Miller of Cedar Grove, New Jersey. Miller is enrolled as a freshman at Seton Hall University in Newark, NJ, where he plans to pursue a degree in business administration.
Miller attended Cedar Grove High School, excelling in athletics. He played varsity baseball, basketball and golf, which he describes as his “passion.” When he was 14, Miller was a national finalist in the Mutual of Omaha Drive, Chip & Putt Junior Challenge in Orlando, Florida, where he placed 6th. Miller’s father introduced him to golf and encouraged him to enter tournaments. He died in 2006 of an abdominal aneurysm.
During his last two years of high school, Miller made the academic honor roll at his high school. He has volunteered at a senior citizen residence and has done fundraising for his chapter, the Hemophilia Association of New Jersey.
Miller has the distinction of being the first child in the world to be treated with a recombinant factor IX product. When he was 4 years old, his parents enrolled him in a clinical trial of the product in Boston to treat his hemophilia B.
The scholarship is named for Kevin Child, who died of AIDS in 1989, shortly before graduating from college. The $1,000 scholarship is awarded annually to a student with hemophilia who is either currently enrolled in or is planning to attend college.
Learn more information on the Kevin Child Scholarship.